Sort   by:  
 Page size 
UnknownRecombination Suppression Drives Expansion of the Drosophila Dot Chromosome.
Not available
S-EPMC12728734 | biostudies-literature
UnknownEfficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial.
Not available
S-EPMC7571408 | biostudies-literature
UnknownLiraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Not available
S-EPMC4985288 | biostudies-literature
UnknownElexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele.
Not available
S-EPMC7282384 | biostudies-literature
UnknownMarkers of Successful Extubation in Extremely Preterm Infants, and Morbidity After Failed Extubation.
Not available
S-EPMC5657557 | biostudies-literature
UnknownTarget ranges of oxygen saturation in extremely preterm infants.
Not available
S-EPMC2891970 | biostudies-literature
UnknownEarly CPAP versus surfactant in extremely preterm infants.
Not available
S-EPMC3071534 | biostudies-literature
UnknownPatterns of Oxygenation, Mortality, and Growth Status in the Surfactant Positive Pressure and Oxygen Trial Cohort.
Not available
S-EPMC5484739 | biostudies-literature
UnknownPrediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants.
Not available
S-EPMC3136997 | biostudies-literature
UnknownTriple Therapy for Cystic Fibrosis Phe508del-Gating and -Residual Function Genotypes.
Not available
S-EPMC8982185 | biostudies-literature
Sort   by:  
 Page size